Murine 4-1BB is an similar to 30-kDa glycoprotein expressed on activat
ed T cells and plays a role in T-cell-mediated proliferative response.
To date the majority of work on 4-1BB has been conducted in the mouse
. To assess the role of 4-1BB in humans, mAbs were made against the re
combinant human (rh) 4-1BB protein. One such mAb 4B4-1 specifically bi
nds SF-21 insect cells expressing rh4-1BB but not irrelevant control p
rotein as measured by how cytometry (FCM). 4B4-1 mAb stains PMA- and i
onomycin-stimulated CEM (human T lymphoma) cells and PHA-stimulated pe
ripheral blood T cells, but not resting cells. 4B4-1 mAb immunoprecipi
tates both similar to 32 and similar to 80 kDa protein from rh4-1BB ex
pressing SF-21 cells and an similar to 39- and similar to 85-kDa prote
in from PMA-stimulated CEM cells under reducing conditions by SDS-PAGE
. As added proof of its specificity, binding of FITC-labeled 4B4-1 mAb
to PHA-stimulated T cells was blocked by rh4-1BB protein. Together th
ese data demonstrate that 4B4-1 is specific for 4-1BB in humans. Unlik
e in the mouse, 4-1BB is expressed much earlier (within 24 hr) peaking
around 2-3 days following PHA stimulation. As in the mouse 4-1BB is i
nduced on both CD4(+) and CD8(+) T cell subsets. 4-1BB expression is i
nduced upon PHA stimulation in both the naive (CD45RA(hi)-CD45RO(lo/-)
) and the memory (CD45RA(lo/-)-RO(hi)) cell populations. Virtually all
CD45RA(hi)RO(lo/-) cells upon culture in PHA give rise to an intermed
iate CD45RA(hi)RO(hi) 4-1BB(+) transitional cell and subsequently CD45
RA(lo/-)RO(hi) 4-1BB(lo/-) and CD45RA(lo/-)RO(hi) 4-1BB(hi) cells. In
contrast, approximately 27% of CD45RA(lo/-)RO(hi) 4-1BB(-) cells when
cultured in PHA for 24 hr acquire 4-1BB expression and all remain CD45
RA(lo/-)RO(hi). (C) 1996 Academic Press, Inc.